Cardlytics Beats Q4 Revenue Estimates, Issues Cautious FY21 Guidance

Cardlytics Inc (NASDAQ: CDLXreported the fourth quarter of FY20  a revenue decline of 3.2% year-on-year to $67.1 million, beating analyst estimates of $60.89 million. 

  • Average FI MAUs (FI monthly active users) rose 22.6% to 163.6 million. ARPU (average revenue per user) declined 21.2% to $0.41.
  • Billings reduced 6.9% to $94 million, and contribution declined 4.4% to $29.7 million.
  • EBITDA declined 35% to $4.5 million. Net loss per share amounted to $0.05, missing the consensus estimate of $0.03 loss.
  • The company lost $7.6 million in operating cash flow.
  • Closing cash and cash equivalents were $293.22 million as of December 31, 2020.
  • The revenue outlook for the first quarter of FY21 lies between $47-53 million, close to the analyst estimate of $50.07 million. Billing estimates fall between $67-75 million. Contribution expectations lie between $20-24 million.
  • Additionally, Cardlytics acquired cash-back offers platform Dosh for $275M in a cash and stock deal.
  • Price action: CDLX stock closed lower by 0.33% at $132.43 on Friday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceTechMedia
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!